Cross Country Healthcare, Inc.CCRNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -28.75% | -25.14% | -22.62% | -19.34% | -20.65% |
| Gross Profit Growth | -34.10% | -31.49% | -24.11% | -20.90% | -20.62% |
| EBITDA Growth | -65.85% | -78.23% | -65.38% | +0.00% | -111.77% |
| Operating Income Growth | -85.95% | -125.57% | -133.45% | +0.00% | -309.36% |
| Net Income Growth | -80.06% | -141.52% | -118.20% | +0.00% | -286.85% |
| EPS Growth | -79.08% | -146.15% | -125.41% | +0.00% | -293.80% |
| EPS Diluted Growth | -78.53% | -146.15% | -125.71% | +0.00% | -294.05% |
| Weighted Average Shares Growth | -5.54% | -6.22% | -5.65% | -4.32% | -1.49% |
| Weighted Average Shares Diluted Growth | -5.96% | -6.77% | -6.69% | -4.32% | -1.62% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -89.38% | +100.71% | -5.49% | -94.88% | +169.26% |
| Free Cash Flow Growth | -90.51% | +135.93% | -0.16% | -97.17% | +182.43% |
| Receivables Growth | -36.89% | -37.46% | -36.92% | -16.01% | -29.05% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -15.59% | -13.26% | -11.14% | -8.14% | -9.91% |
| Book Value per Share Growth | -4.27% | -5.63% | -5.32% | -1.87% | -2.44% |
| Debt Growth | -24.29% | -26.50% | -26.31% | -41.57% | -50.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -22.02% | -22.78% | +0.00% | +0.00% | -100.00% |